Chartwell Retirement Residences (CSH.UN.TO)…

Chartwell Retirement Residences (CSH.UN.TO)

19.35

-0.10 (0.51%)

as of Oct 9, 2026, 8:00:00 pm Market Open.

522 watching

BUY

Allan Tong’s Discover Picks Since then, residents and staff have been fully jabbed and Chartwell’s vacancy rate has been recovering from a bottom of 80% after scaling 93% pre-Covid. Accordingly, the share price has climbed 17% to $13.60 as of this writing. Moreover, CSH.UN has restored its place as an income stock, paying a 4.51% dividend yield, which is in line with healthcare facilities. Since November, CSH stock has met its previous price target of $12.32 and is closing in on the current PT of $13.63, based on one buy and one hold signal, both published in early May. I expect an upgrade after a positive earnings report on August 5, which will cover the early Canadian reopening phase of April through June. Chartwell is not a trade, but a long-term investment that pays a reliable dividend and will be driven by demographics as more Canadians age. Read 3 Post-Covid Recovery Stocks to Buy for our full analysis.

Wealthica Track your Stocks in your Watch List

HOLD

Income stock. Hit hard by Covid. Vaccines should help occupancy rates rebound. Need has not disappeared. Stock price has rebounded, but still room to move. Less supply moving in, from Covid overhang, will also be positive for occupancy.

DON'T BUY

Best of them all in the senior living space. There are always issues either with property, regulation, demographics, over supply, or the pandemic. Drop may present a decent buying opportunity. Difficult to value, as it's a communal living space. He finds much easier investments elsewhere.

TOP PICK

During Covid they lost a lot of occupancy and it was a tough sector during Covid. But now we're close to the bottom or past it. About 90% of CSH residents have gotten a vaccine. Compared to U.S. peers, CSH trades at a big discount with better fundamentals than most U.S. peers. CSH trades at 13.5x earnings vs. 20x in the U.S. They have a long way to go, though, and must raise occupancy by 10%, but he believes this will happen. Trades at a huge NAV discount. Note: this isn't a nursing home, which endures a cloud over it, but a retirement home. (Analysts’ price target is $12.71)

PAST TOP PICK

(A Top Pick Dec 16/19, Down 20%) A company that has been hit hard by the pandemic. They were having some problems prior due to supply on the market. Occupancy has come down from 93% to 80% in the last 12 months due to the pandemic restrictions. A first class operator and demographics are in favour of the company. Currently trading at less than 14x cashflow and pays 5.5% dividend. Continues to buy it.

SELL

Sees a bit of softness coming for seniors housing. Covid has elevated expenses. Operating margins pressured in an already tight sector. People are delaying opportunities to put loved ones into a home. Oversupply, which will take 2-3 years to fill up. Sell, and re-enter when we see what the new normal will be.

BUY

Allan Tong’s Discover Picks Chartwell jumped 13% on the Pfizer vaccine news and 3% on the Moderna. Since Nov. 9, the stock has been bubbling between $11-12. There's a little more room to run to its $12.32 price target. Rising Covid cases will challenge these LTC stocks, but more positive vaccine news will propel it further. Analyst and shareholder, Christine Poole, is reasonably correct in predicting CSH.UN will return to pre-Covid levels above $14 in 12 months or more. At least you're paid 5.14% to wait. Read 4 Reliable Covid Stocks and Recovery Stocks for our full analysis.

BUY ON WEAKNESS

Re-rating of seniors REITs. Prefers Chartwell to Sienna. SIA dividend is good, payout ratio should start looking better. Low valuation. You can buy both on weakness.

WATCH

Shares down significantly. Long-term demographic story remains intact. But now the fear in seniors housing has risen. Costs of health protection will increase, but dividend can be maintained and grow. On sale for a reason. Will be watching carefully through the winter.

BUY

Got hit really hard with Covid. Weren't able to do showings to new clients. There will be a slow improvement over time. Whole industry remains attractive. Excellent operator. Might take more than 12 months to get to pre-Covid levels.

HOLD

Management has done a great job navigating the virus earlier this year. The sector has taken a hit. Pleased with their occupancy rates, higher than he expected, and in keeping their residents. It's trading at a discount NAV. Hold if you own, but there will be choppiness in months or quarters to come, given Covid headlines. CSH can weather that though. The value of the real estate will still be there, and they are good operators.

TOP PICK

There has been negativity in the news with long-term care facilities in general. 90% of their revenues comes from private pay retirement residences. Their FFO growth has not been strong due to lower occupancy and costs due to covid. They have good tailwinds and occupancy will go back up. (Analysts’ price target is $11.79)

BUY

He doesn't like REITs. Commercial residential ones will be hard-pressed for a long time, but he actually added to CSH the other day. Why? Not everybody can do seniors housing, and CSH's latest report said that overall occupancy wasn't bad. CSH trades at a cheap 11.8x 2021 with a 73% 2021 payout ratio. Their 6% dividend is paying you well and safe. He expects the next two quarters to be tough, but will recover in 2021. Fine value.

BUY

The demographics are attractive in seniors housing and this won't go away. The pandemic did strain long-term care homes, but CSH has only 10% in this area. Their main business are luxury retirement homes. Their occupancy rate did decline because tours and move-ins were forbidden during the lockdown, but each week since the lockdown occupancy slightly climbs. Occupancy should improve going forward. Seniors continue to need help in accommodation. CSH has had to spend more on PPP equipment in response to the pandemic. The industry has learned a lot from the pandemic and will be better prepared if there's a second wave. The Ontario government has announced funding programs to address deficiencies in LTCs.

DON'T BUY

She once owned it. The retirement sector was weak even before COVID due to oversupply of seniors' housing in Canada. (CSH has only 15% exposed to long-term care.) She expects ongoing occupancy decline, and with COVID expenses will impact their 2020 revenues. This stock is on hold, though the seniors housing sector is attractive long-term. The stock will stay cheap until COVID is resolved and the oversupply ends.

Showing 91 to 105 of 492 entries

Most Recent Experts

Jim Cramer - Mad Money

CNBC

Brian Madden

First Avenue Investment Counsel

Jamie Murray

Murray Wealth Group

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Halloween Sale

Chartwell Retirement Residences (CSH.UN.TO)